Adverse reactions to non-steroidal antirheumatic drugs.
D000700:Analgesics / Q000009:adverse effects* / Q000633:toxicity; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000633:toxicity; D001241:Aspirin / Q000009:adverse effects; D001577:Benzophenones / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006046:Gold / Q000009:adverse effects; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D008099:Liver / Q000187:drug effects; D009280:Naphthaleneacetic Acids / Q000009:adverse effects; D010113:Oxyphenbutazone / Q000009:adverse effects; D010396:Penicillamine / Q000009:adverse effects; D010615:Phenacetin / Q000009:adverse effects; D010647:Phenyl Ethers / Q000009:adverse effects; D010648:Phenylacetates / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D011422:Propionates / Q000009:adverse effects; D012042:Registries; D006113:United Kingdom
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001577:Benzophenones; D009280:Naphthaleneacetic Acids; D010647:Phenyl Ethers; D010648:Phenylacetates; D011422:Propionates; D006046:Gold; D010615:Phenacetin; D010653:Phenylbutazone; D010396:Penicillamine; D010113:Oxyphenbutazone; D001241:Aspirin; D007213:Indomethacin